Manchester, CT2 Active Studies

Erectile Dysfunction Clinical Trials in Manchester, CT

Find 2 actively recruiting erectile dysfunction clinical trials in Manchester, CT. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
715
Enrolling

Recruiting Erectile Dysfunction Studies in Manchester

About Erectile Dysfunction Clinical Trials in Manchester

Erectile dysfunction is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It affects about 30 million men in the U.S. and is often a sign of underlying cardiovascular disease. Treatment includes PDE5 inhibitors, vacuum devices, and penile implants.

There are currently 2 erectile dysfunction clinical trials recruiting participants in Manchester, CT. These studies are seeking a combined 715 participants. Research is being sponsored by BioNTech SE, Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Erectile Dysfunction Clinical Trials in Manchester — FAQ

Are there erectile dysfunction clinical trials in Manchester?

Yes, there are 2 erectile dysfunction clinical trials currently recruiting in Manchester, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Manchester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Manchester research site will contact you about next steps.

Are clinical trials in Manchester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Manchester studies also compensate for your time and travel.

What erectile dysfunction treatments are being tested?

The 2 active trials in Manchester are testing new therapies including novel drugs, biologics, and treatment approaches for erectile dysfunction.

Data updated March 2, 2026 from ClinicalTrials.gov